Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding GB:JREC?
Track your performance easily
GB:JREC Price & Analysis
JREC ETF Chart & Stats
Day’s Range― - ―
52-Week Range$15.83 - $24.17
Previous Close$20.07
VolumeN/A
Average Volume (3M)2.00K
AUM27.88M
NAV20.32
Expense Ratio0.47%
Holdings Count311
Beta0.46
Inception DateFeb 15, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.07
10 Day Avg. Volume328
30 Day Avg. Volume2,003
Alpha-0.00728
China A Research Enhanced Index Equity (ESG) UCITS ETF Accum-USD- (JREC) Fund Flow Chart
China A Research Enhanced Index Equity (ESG) UCITS ETF Accum-USD- (JREC) 1 year Net Flows: $7M
JREC ETF FAQ
What was GB:JREC’s price range in the past 12 months?
GB:JREC lowest ETF price was $15.82 and its highest was $24.17 in the past 12 months.
What is the AUM of GB:JREC?
As of Nov 12, 2024 The AUM of GB:JREC is 27.88M.
Is GB:JREC overvalued?
According to Wall Street analysts GB:JREC’s price is currently Undervalued.
Does GB:JREC pay dividends?
GB:JREC does not currently pay dividends.
How many shares outstanding does GB:JREC have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:JREC?
Currently, no hedge funds are holding shares in GB:JREC
Top 10 Holdings
Kweichow Moutai Co., Ltd. Class A
5.14%
Contemporary Amperex Technology Co., Ltd. Class A
2.96%
China Merchants Bank Co., Ltd. Class A
2.18%
China Yangtze Power Co., Ltd. Class A
1.83%
Ping An Insurance (Group) Company of China, Ltd. Class A
1.83%
Wuliangye Yibin Co., Ltd. Class A
1.59%
CITIC Securities Co. Ltd. Class A
1.40%
BYD Company Limited Class A
1.39%
Agricultural Bank of China Limited Class A
1.20%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A
1.12%
Total20.64%
ETF Description
China A Research Enhanced Index Equity (ESG) UCITS ETF Accum-USD-
The objective of the Sub-Fund is to achieve a long-term return in excess of the Benchmark by actively investing primarily in a portfolio of Chinese companies.